Expert shares the evolving role of pharmacy in patient care, emphasizing treatment accessibility and monitoring.
Yi Lin, MD, PhD
Advertisement
Articles by Yi Lin, MD, PhD
Outpatient use of bispecifics and CAR T-cell therapies in multiple myeloma can expand access.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
5